Noxopharm Limited (NOX.AX)
AUD 0.07
(0.0%)
AUD 0.07
(0.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 | 1.28 Million AUD | 22.12% |
| 2023 | 1.05 Million AUD | -57.38% |
| 2022 | 2.47 Million AUD | -65.02% |
| 2021 | 7.07 Million AUD | -1.63% |
| 2020 | 7.19 Million AUD | 25.1% |
| 2019 | 5.75 Million AUD | 30.66% |
| 2018 | 4.4 Million AUD | 1119.07% |
| 2017 | 361.04 Thousand AUD | 37.95% |
| 2016 | 261.72 Thousand AUD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 580.76 Thousand AUD | 0.0% |
| 2024 Q4 | 1.28 Million AUD | 0.0% |
| 2024 FY | 1.28 Million AUD | 22.12% |
| 2023 FY | 1.05 Million AUD | -57.38% |
| 2023 Q2 | 3.21 Million AUD | 0.0% |
| 2023 Q4 | 1.05 Million AUD | 0.0% |
| 2022 Q2 | 2.45 Million AUD | 0.0% |
| 2022 FY | 2.47 Million AUD | -65.02% |
| 2022 Q4 | 2.47 Million AUD | 0.0% |
| 2021 Q2 | 6.36 Million AUD | 0.0% |
| 2021 FY | 7.07 Million AUD | -1.63% |
| 2021 Q4 | 7.07 Million AUD | 0.0% |
| 2020 FY | 7.19 Million AUD | 25.1% |
| 2020 Q4 | 7.19 Million AUD | 0.0% |
| 2020 Q2 | 9.05 Million AUD | 0.0% |
| 2019 Q2 | 4.81 Million AUD | 0.0% |
| 2019 Q4 | 5.75 Million AUD | 0.0% |
| 2019 FY | 5.75 Million AUD | 30.66% |
| 2018 Q4 | 4.4 Million AUD | 0.0% |
| 2018 FY | 4.4 Million AUD | 1119.07% |
| 2018 Q2 | 961.46 Thousand AUD | 0.0% |
| 2017 Q2 | 152.15 Thousand AUD | 0.0% |
| 2017 FY | 361.04 Thousand AUD | 37.95% |
| 2017 Q4 | 361.04 Thousand AUD | 0.0% |
| 2016 FY | 261.72 Thousand AUD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| AdAlta Limited | 3.54 Million AUD | 63.625% |
| Biome Australia Limited | 5.37 Million AUD | 76.018% |
| Radiopharm Theranostics Limited | 44.68 Million AUD | 97.116% |
| Biotron Limited | 737.5 Thousand AUD | -74.725% |
| Acrux Limited | 5.68 Million AUD | 77.341% |
| Alterity Therapeutics Limited | 5.42 Million AUD | 76.25% |
| Botanix Pharmaceuticals Limited | 3.73 Million AUD | 65.472% |
| BTC Health Limited | 203.94 Thousand AUD | -531.835% |
| Chimeric Therapeutics Limited | 12.8 Million AUD | 89.935% |
| CSL Limited | 27.88 Billion AUD | 99.995% |
| Clarity Pharmaceuticals Ltd | 8.33 Million AUD | 84.534% |
| Clinuvel Pharmaceuticals Limited | 28.11 Million AUD | 95.416% |
| Immutep Limited | 10.97 Million AUD | 88.264% |
| Memphasys Limited | 5.59 Million AUD | 76.958% |
| Neuren Pharmaceuticals Limited | 42.76 Million AUD | 96.987% |
| Prescient Therapeutics Limited | 2.32 Million AUD | 44.589% |
| Race Oncology Limited | 1.91 Million AUD | 32.759% |
| Starpharma Holdings Limited | 8.69 Million AUD | 85.185% |
| Tissue Repair Ltd | 1.35 Million AUD | 4.611% |
| EZZ Life Science Holdings Limited | 4.22 Million AUD | 69.53% |
| Anatara Lifesciences Ltd | 306.84 Thousand AUD | -319.951% |
| Bio-Gene Technology Limited | 368.44 Thousand AUD | -249.743% |
| Zelira Therapeutics Limited | 9.35 Million AUD | 86.228% |
| Patrys Limited | 691.36 Thousand AUD | -86.387% |
| Orthocell Limited | 22.08 Million AUD | 94.165% |
| Imugene Limited | 33.14 Million AUD | 96.112% |
| PYC Therapeutics Limited | 10.18 Million AUD | 87.347% |
| Proteomics International Laboratories Limited | 1.62 Million AUD | 20.746% |
| Cynata Therapeutics Limited | 1.17 Million AUD | -10.039% |
| Arovella Therapeutics Limited | 2.05 Million AUD | 37.344% |
| Nanollose Limited | 465.64 Thousand AUD | -176.739% |
| Invex Therapeutics Ltd | 431.63 Thousand AUD | -198.546% |
| NeuroScientific Biopharmaceuticals Limited | 85.68 Thousand AUD | -1403.932% |
| Amplia Therapeutics Limited | 3.42 Million AUD | 62.396% |
| Island Pharmaceuticals Limited | 1.04 Million AUD | -23.239% |
| Nyrada Inc. | 855.63 Thousand AUD | -50.604% |
| Telix Pharmaceuticals Limited | 249.39 Million AUD | 99.483% |
| Dimerix Limited | 13.89 Million AUD | 90.725% |
| PharmAust Limited | 896.6 Thousand AUD | -43.721% |
| Hexima Limited | 248.67 Thousand AUD | -418.202% |
| AnteoTech Limited | 4.07 Million AUD | 68.38% |
| Paradigm Biopharmaceuticals Limited | 3.58 Million AUD | 64.049% |
| Recce Pharmaceuticals Ltd | 15.89 Million AUD | 91.892% |
| Avecho Biotechnology Limited | 941.54 Thousand AUD | -36.862% |
| Actinogen Medical Limited | 1.61 Million AUD | 20.228% |
| Immuron Limited | 2.84 Million AUD | 54.635% |
| Argenica Therapeutics Limited | 2.42 Million AUD | 46.899% |